A baseline sample was drawn 15 minutes before the MTT and during the postprandial period nine blood samples for glucose and insulin were drawn at the following timepoints: 15, 30, 60, 120, 180, 240, 300, 360, and 480 minutes.
A baseline sample was drawn 10 minutes before the MTT and during the postprandial period nine blood samples were drawn at the following timepoints: 15, 30, 45, 60, 90, 120, 180, 240, and 300 minutes.
There were no significant correlations between the changes from baseline in 25(OH D and NT-proBNP (r = -0.04, p = 0.8) whether the baseline sample was drawn <14 or ≥ 14 days postpartum (r = -0.3, p = 0.2 and r = 0.1, p = 0.6; respectively) (Fig 2).
Baseline plasma samples were drawn and hyperinsulinemic-euglycemic clamps were performed in the morning after a 10 hr fast as previously described [20].
Baseline blood samples were drawn for A1C, cholesterol, triglycerides, glucose, insulin, C-peptide, and other biochemicals.
Baseline screening samples were drawn at time point 0, and blood samples (glucose and insulin) were drawn every 30 minutes for two hours.
After baseline blood samples were drawn, subjects were administered a primed (5 mg/kg) continuous (3 mg/kg/h) infusion of 6,6-H2 gluCambridgebrIsotopestopes Laboratories, Andover, MA) for 120 min to estimate basal EGP.
Baseline blood samples were drawn in-hospital; additional venipunctures were performed prior to hospital discharge, and at 3-months either in-hospital (for patients remaining in acute care or rehabilitation) or at the out-patient clinic visit.
From 8 00 a.m. (baseline), blood samples were drawn hourly for determination of serum concentrations of IGFBP-1 and IGFBP-2, while total IGF-I, bioactive IGF and IGFBP-3 were measured at 0, 3, 6, and 9 hours.
Participants arrived at 07 30 hours at the university after an overnight fast and baseline blood samples were drawn to measure glucose, insulin and NEFA followed by the start of the [6,6-H2]glucose infusion.
